Status:
COMPLETED
Descriptive Epidemiology on Management of Mucormycosis
Lead Sponsor:
Fungal Infection Study Forum
Collaborating Sponsors:
Mylan India Limited
Conditions:
Mycoses
Eligibility:
All Genders
1-90 years
Brief Summary
This is an observational chart review of all patients with confirmed and probable diagnosis of mucormycosis at 19 centers across Indian hospital. Data will collect using a standardized CRF. All collec...
Detailed Description
Introduction Mucormycosis is a life threatening angio-invasive fungal infection generally occurring in immunocompromised individuals. In recent years the incidence has increased globally and alarming...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All consecutive patients regardless of age with a confirmed diagnosis mucormycosis through HPE \& /or culture will be enrolled in this study. In suspected cases on histopathology, molecular technique of extraction of DNA from tissue and sequencing to identify the pathogen, will be used to confirm the diagnosis
- All probable cases of mucormycosis.
Exclusion
Key Trial Info
Start Date :
April 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2017
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03429023
Start Date
April 1 2016
End Date
September 30 2017
Last Update
February 12 2018
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Sterling Hospital
Ahmedabad, Gujarat, India, 380052
2
St.Johns Medical College
Bangalore, Karnataka, India, 560034
3
PD Hinduja National Hospital and Medical Research centre
Mumbai, Maharashtra, India, 400016
4
All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, India, 110029